untreated%20indolent%20Non-Hodgkin's%20Lymphoma
Showing 9976 - 10000 of >10,000
Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an
Recruiting
- Metastatic Solid Tumor Cancer
- Dose escalation, first-in-human phase I clinical trial with an Expansion phase
-
Caen, France
- +2 more
Oct 11, 2022
Septic Shock, Shock, Sepsis Trial (Angiotensin II and hydrocortisone sodium succinate)
Not yet recruiting
- Septic Shock
- +3 more
- Angiotensin II and hydrocortisone sodium succinate
- (no location specified)
Nov 3, 2023
Lymphedema of Leg, Gynecologic Cancer, Exercise Trial (Home-based exercise)
Completed
- Lymphedema of Leg
- +2 more
- Home-based exercise
- (no location specified)
Dec 23, 2022
Body Fat Disorder Trial in Pleasanton (The Zeltiq CoolSculpting System)
Completed
- Body Fat Disorder
- The Zeltiq CoolSculpting System
-
Pleasanton, CaliforniaInnovation Research Center
Dec 1, 2021
Healthy Participants Trial in New Haven (PF-07284890 Treatment A, PF-07284890 Treatment B, PF-07284890 Treatment C)
Recruiting
- Healthy Participants
- PF-07284890 Treatment A
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 28, 2022
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in United States (NBF-006)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Beverly Hills, California
- +8 more
Dec 21, 2021
Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma Trial in Tianjin (Disitamab Vedotin Tislelizumab,
Recruiting
- Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- Disitamab Vedotin Tislelizumab
- Disitamab Vedotin
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 9, 2022
Hemodynamic Instability Trial in Seoul (REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for
Recruiting
- Hemodynamic Instability
- REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 8, 2022
Chronic Stroke Trial (Active Vibrotactile coordinated reset, Sham vibrotactile coordinated reset)
Not yet recruiting
- Chronic Stroke
- Active Vibrotactile coordinated reset
- Sham vibrotactile coordinated reset
- (no location specified)
Aug 5, 2022
Active Non Segmental Vitiligo Trial in Cairo (Narrow band ultraviolet B)
Completed
- Active Non Segmental Vitiligo
- Narrow band ultraviolet B
-
Cairo, Helwan, EgyptNourhan Emad
Aug 8, 2022
Liver Fibrosis Trial in Rochester (Mechanical Vibrations with Ultrasound Shear Wave Imaging)
Completed
- Liver Fibrosis
- Mechanical Vibrations with Ultrasound Shear Wave Imaging
-
Rochester, MinnesotaMayo Clinic
Dec 10, 2021
Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)
Not yet recruiting
- Crohn Disease
- Ulcerative Colitis
- Adalimumab-680LT
- Control
- (no location specified)
Oct 30, 2023
Rehabilitation Trial in Konya (High Induction Magnetic Field Therapy, Conservative Treatment)
Recruiting
- Rehabilitation
- High Induction Magnetic Field Therapy
- Conservative Treatment
-
Konya, Karatay, TurkeyKTO Karatay University
Nov 3, 2023
Nephrectomy, Prostatectomy Trial in Barcelona (Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy
Recruiting
- Nephrectomy
- Prostatectomy
- Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN) or Radical Prostatectomy (RP).
-
Barcelona, SpainHospital Clínic de Barcelona
Nov 6, 2023
Dexmedetomidine, Postoperative Delirium, Deep Brain Stimulation Trial in Beijing (Dexmedetomidine, 0.9% saline)
Not yet recruiting
- Dexmedetomidine
- +2 more
- Dexmedetomidine
- 0.9% saline
-
Beijing, Beijing, ChinaBeijing Tian Tan Hospital, Capital Medical University
Feb 28, 2022
COVID-19, Post-COVID-19 Syndrome, Post COVID-19 Condition Trial in Madrid (transcranial current direct stimulation)
Recruiting
- COVID-19
- +2 more
- transcranial current direct stimulation
-
Madrid, SpainHospital Clínico San Carlos.
Mar 2, 2023
Group A Streptococcal Infection Trial in Madison (LolliTest, Lollipop Swab)
Not yet recruiting
- Group A Streptococcal Infection
- LolliTest
- Lollipop Swab
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jul 18, 2022
Baseline Concentration of Direct Oral Anticoagulant and
Recruiting
- Atrial Fibrillation
- Anticoagulant-induced Bleeding
-
Cremona, ItalySophie Testa
Jul 19, 2022
Rheumatoid Arthritis Trial in Beijing (hUC-MSC infusion (BC-U001))
Recruiting
- Rheumatoid Arthritis
- hUC-MSC infusion (BC-U001)
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (Dongdan campus)
Jul 18, 2022
Intracranial Blood Flow and Peripheral Perfusion in
Completed
- Brain-injury
- Intracranial; Blood Vessel, Injury
-
Beijing, Beijing, ChinaWei Du
Aug 23, 2023
Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL Trial in
Completed
- Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL
-
Nagoya, Aichi, Japan
- +28 more
Oct 19, 2020
Menopause, Sleep, Fatigue Trial in Adana (Therapeutic Touch, Mimic touch)
Recruiting
- Menopause
- +3 more
- Therapeutic Touch
- Mimic touch
-
Adana, Saricam, TurkeyOzlem Yalcinkaya
Jan 4, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,
Recruiting
- Lung Non-Small Cell Carcinoma
- +15 more
- Best Practice
- +2 more
-
Portland, Oregon
- +1 more
Jun 8, 2022